位置:成果数据库 > 期刊 > 期刊详情页
胰腺癌淋巴转移分子机制研究进展
  • ISSN号:1006-1533
  • 期刊名称:《上海医药》
  • 分类:R735.9[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:复旦大学附属肿瘤医院胰腺外科复旦大学上海医学院肿瘤学系复旦大学胰腺肿瘤研究所,上海200032
  • 相关基金:国家自然科学基金资助项目(81101807,81001058,81372649,81372653,81172276)
中文摘要:

胰腺癌是实体肿瘤中恶性程度最高的肿瘤之一,具有发病隐匿、手术切除率低、局部侵袭性强、早期容易发生转移、术后易复发、总体预后极差等特点。淋巴转移是胰腺癌最主要的转移方式,也是胰腺癌患者的早期不良预后事件,同时也是胰腺癌术后独立不良预后因子。胰腺癌淋巴转移的发生并不是偶然或随机事件,而更像是由肿瘤细胞与其周围微环境共同精心策划的。越来越多的研究表明,肿瘤转移起始细胞(或肿瘤干细胞)与肿瘤微环境在胰腺癌淋巴转移中起着"唱双簧"的作用。然而,参与整个转移过程的细胞与分子机制复杂,尚未完全阐明。本文结合近年相关文献对胰腺癌淋巴转移的细胞分子机制进行讨论。

英文摘要:

Pancreatic cancer is widely known as one of the most challenging human malignancies for its insidious symptoms,low rate of surgical resection,high risk of local invasion,metastasis and recurrence,and overall dismal prognosis.Lymphatic metastasis,above all,is recognized as an early adverse event in progression of pancreatic cancer and has been described to be an independent poor prognostic factor.It should be noted that the occurrence of lymphatic metastasis is not a casual or stochastic but an ineluctable and designed event.Increasing evidences suggest that metastasis-initiating cells and the microenvironments may act as a double-reed style in this crime.However,the exact mechanism on how they function synergistically for this dismal clinical course is intricate and remains largely elusive.Therefore,a better understanding of its molecular and cellular mechanisms involved in pancreatic lymphatic metastasis is urgently required.In this review,we summarize the latest advances in lymphatic metastasis in pancreatic cancer.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《上海医药》
  • 主管单位:上海市经济和信息化委员会
  • 主办单位:上海医药行业协会
  • 主编:
  • 地址:上海市凤阳路250号
  • 邮编:200003
  • 邮箱:
  • 电话:021-63276921
  • 国际标准刊号:ISSN:1006-1533
  • 国内统一刊号:ISSN:31-1663/R
  • 邮发代号:4-592 4-864
  • 获奖情况:
  • 多次被评为华东地区优秀科技期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版)
  • 被引量:11839